About Notocord
Notocord is a Healthcare company based in Croissy-sur-seine (France) founded in 1989, and was acquired by Instem in September 2016. Life sciences software publisher. The company was acqui-hired. Its focus areas include HealthTech, Life Sciences Tech, Diversified and Life Sciences.
Company details
Notocord provides measurement and analysis software preclinical RD, including efficacy testing, early safety, regulatory safety pharmacology and toxicology studies. Solutions include NOTOCORD-hem- a software platform designed to acquire, display and analyze physiological signals and NOTOCORD-fps- a software to process cardiomyocyte field potentials signals from 3 MEA manufacturers, squizz raw data.
- Headquarters Croissy-sur-seine, France
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website notocord.com
- Social LinkedIn Facebook
- Acquired by Instem (Sep 2016)
Funding Insights of Notocord
- Total Rounds 1
- Last Round Grant — $647,430
- First Round $647,430
(Jan 2020)
- Investors Count 1
All 1 funding rounds of Notocord with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2020 | $647,430 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in Notocord
Notocord has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Instem and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Software for life science data collection and analysis is provided. | 1969 | instem.com | Conshohocken, United States |
Investor details for Notocord
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Notocord
3 dated milestones of Notocord across 31 years, from founding to its latest funding, stage changes and deals.
- Founded Notocord is founded.
- Exit Acquired by Instem.
- Funding First funding round of $647K.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Notocord
Notocord was founded in 1989 and raised its 1st funding round 31 years after it was founded.
Notocord is headquartered in Croissy-sur-seine, France.
Notocord provides measurement and analysis software preclinical RD, including efficacy testing, early safety, regulatory safety pharmacology and toxicology studies. Solutions include NOTOCORD-hem- a software platform designed to acquire, display and analyze physiological signals and NOTOCORD-fps- a software to process cardiomyocyte field potentials signals from 3 MEA manufacturers, squizz raw data.
Notocord has 2 investors. Key investors include Instem, and European Union.
Yes. Notocord was acquired by Instem in September 2016.